CannaRoyalty Announces its First Quarter 2018 Financial Results

OTTAWA, May 29, 2018 /CNW/ - CannaRoyalty Corp. (CSE: CRZ) (OTCQX: CNNRF) ("CannaRoyalty" or the "Company") today announced the Company's financial results for the three-month period ended March 31, 2018. All figures are reported in Canadian dollars ($), unless otherwise indicated. CannaRoyalty's financial statements are prepared in accordance with International Financial Reporting Standards ("IFRS").

"Over the past six months, we have announced the acquisition of substantial revenue generating cannabis operators, including distribution operations that generated US$31.9 million in revenue in 2017, transforming CannaRoyalty into a major cannabis product distributor in California and into what we expect will be one of the largest revenue producers in the Canadian publicly-traded cannabis space," said Marc Lustig, CEO of CannaRoyalty. "Our team has targeted distribution not only for its attractive near-term economic potential but also for its strategic position between California's leading growth brands and most licensed dispensaries in the state. By fostering strategic relationships with both constituencies, we expect to generate significant organic growth, while building an information advantage and poll position to assess and execute on accretive opportunities for the Company. Over the past several months we have also established a beachhead in Canada to eventually bring our leading products home and we expect to continue to make progress on this significant opportunity over the balance of the year and as the Canadian regulations continue to develop."

Q1 Highlights and Recent Developments

For a more comprehensive overview of these highlights and recent developments, please refer to CannaRoyalty's Management's Discussion and Analysis of the Financial Condition and Results of Operations for the Three Months Ended March 31, 2018.

• On May 11, 2018 Trichome and CannaRoyalty jointly closed a first tranche of $500,000 under a credit agreement to provide up to $2.5 million to 180 Smoke, a leading Canadian online and retail vaporizer products company.
• On April 18, 2018, CannaRoyalty announced it was planning to acquire 100% of FloraCal Farms, a licensed ultra-premium craft cannabis producer. The acquisition of FloraCal will add branded premium cannabis flower and pre-roll products to CannaRoyalty's diverse portfolio.
• On March 27, 2018, CannaRoyalty announced it had closed the acquisition of Alta Supply Inc. a California based licensed cannabis distributor and of Kaya Management Inc., the exclusive manufacturer and license holder of rights for Bhang® brand vaporizer products in California, as well as the acquisition of the exclusive statewide manufacturing and distribution rights to Bhang® edibles and Bhang® concentrates in California.
• On March 25, 2018, the Company announced that it entered into a binding term sheet for the acquisition of 100% of River Distribution and its affiliates to further expand its owned-distribution network across the state of California.

Financial Highlights – Q1 – 2018

Operating Results
All comparisons below are to March 31, 2017, unless otherwise noted

• Revenues were $643,437 as compared to $301,111.
• Gross margin was ($29,630) as compared to $244,473.
• Operating expenses were $4.5 million as compared to $3.1 million.
• Net loss of $4.7 million as compared to $2.1 million.
• Net loss per share of $0.10 as compared to $0.05.
• Adjusted EBITDA loss of $2.1 million as compared to $1.6 million.
• Adjusted EBITDA loss per share of $0.05 as compared to $0.04.

Balance Sheet
All comparisons below are to December 31, 2017, unless otherwise noted

• Cash and cash equivalents of $6,056,470 as compared to $4,522,644.
• Total assets of $67,670,691 as compared to $46,139,757.
• Current assets of $11,530,330 as compared to $7,947,975.
• Current liabilities of $7,928,271 as compared to $2,134,270.
• Long-term debt of $2,569,094 as compared to $2,258,467.
• Shareholders' equity of $53,740,121 as compared to $40,468,344.

Results of Operations (Summary)
The following tables set forth consolidated statements of financial information for the three-month periods ending March 31, 2018 and March 31, 2017. For further information regarding the Company's financial results for these periods, please refer to the Company's Management's Discussion and Analysis for the periods ended March 31, 2018 and March 31, 2017 and the Company's Financial Statements for the periods ended March 31, 2018, published on CannaRoyalty's issuer profile on SEDAR at www.sedar.com and the Company's website at www.cannaroyalty.com.

Revenue Components
		Three months ended March 31
		2018		2017
Product sales		$	84,773	$	-
Services		429,817		71,045
Royalties		119,058		211,322
Interest income		9,789		18,744
Total		$	643,437	$	301,111
Cost of sales by revenue type
		Three months ended March 31
		2018		2017
Cost of product sales		$	75,673	$	-
Cost of services		209,023		11,810
Cost of royalties		388,371		44,828
Total		$	673,067	$	56,638
Gross margin amounts and percentages by revenue type
		Three months ended March 31
		2018		2017
Products		$	9,099	$	-
Services		220,794		59,235
Royalties		(269,312)		166,494
Interest		9,789		18,744
Total		$	(29,630)	$	244,473
	Three months ended March 31
		2018		2017
Products		11%		n/a
Services		51%		83%
Royalties		(226%)		79%
Interest		100%		100%
All Types		(5%)		81%
Operating Expenses
		Three months ended March 31
		2018		2017
Sales and marketing		$	478,516	$	236,860
Research and development		75,965		476,241
General and administrative		3,750,426		2,137,188
Amortization of intangibles		175,107		202,472
Total		$	4,480,014	$	3,052,761

Adjusted EBITDA^2
		Three months ended March 31
		2018		2017
Add (Subtract)
Net loss for the period		$	(4,654,473)	$	(2,053,785)
	Amortization of property and equipment	45,268		41,742
	Amortization of intangible assets	175,107		202,472
	Amortization of royalty investments	388,370		28,263
	Interest expense	319,990		17,620
	Interest income	(9,789)		(18,744)
	Current income taxes	434		-
	Deferred income tax recovery	168,813		(78,372)
EBITDA		(3,566,280)		(1,860,804)
	Gains on investments	(342,106)		-
	Impairment of convertible notes receivable	375,472		-
	Listing expense	-		38,193
	Gain on reclassification to assets held for sale	-		(98,674)
	Adjustment from non-completion of share swap transaction	-		183,475
	Share based compensation	1,940,043		1,158,396
	Gain on dilution of equity accounted investment	(846,925)		(1,132,107)
	Transaction costs on acquisitions	282,126		-
	Foreign exchange	76,030		125,652
TOTAL ADJUSTED EBITDA		$	(2,081,640)	$	(1,585,869)
Weighted average number of common shares outstanding - basic and diluted		45,075,695		38,865,970
ADJUSTED EBITDA per share - basic and diluted		$	(0.05)	$	(0.04)

²Adjusted EBITDA and Adjusted EBITDA per share are non-IFRS measures. See "Adjusted EBITDA" in the Company's Management's Discussion and Analysis for the three and twelve-month periods ended March 31, 2018. 

Share Capital

The Company's authorized share capital is an unlimited number of common shares of which 46,907,628 were issued and outstanding as at March 31, 2018 (December 31, 2017 – 43,898,445 common shares). The Company has issued 4,109,650 RSUs that have not been exercised as at March 31, 2018 including 2,375,922 that have vested (December 31, 2017 – 4,153,150 including 1,933,587 that had vested).  As of March 31, 2018, there are share purchase warrants and broker warrants outstanding that can potentially be converted to 2,623,491 shares (December 31, 2017 – 4,112,712).

Conference Call

CannaRoyalty will host a conference call on, Tuesday, May 29, 2018 at 8:30 a.m. (Eastern Time) to discuss its 2018 first quarter financial results. The call will be chaired by Marc Lustig, Chief Executive Officer, Afzal Hasan, President and General Counsel and François Perrault, Chief Financial Officer.

	Participant Dial-in	Webcast	Reference Number
Conference Call	647-427-7450; or 1-888-231-8191	https://bit.ly/2G0yhbz
Replay (available for 2 weeks)	416-849-0833; 613-667-0035; or 1-855-859-2056		5898535

About CannaRoyalty

CannaRoyalty is an active operator and investor in the global cannabis industry, with a strong focus on California, the world's largest cannabis market. Our core mission is to become the leading global consumer product goods company for discerning cannabis consumers. We are currently focused on building a diversified portfolio of manufacturing, distribution, intellectual property, and infrastructure assets to achieve this goal. Our leadership team combines a passion and hands-on understanding of the cannabis industry, with seasoned financial and legal expertise. CannaRoyalty's shares trade on the Canadian Stock Exchange (CSE) under the symbol CRZ and internationally on the OTCQX under the symbol CNNRF.

Forward Looking Statements

Statements in this news release that are forward-looking statements are subject to various risks and uncertainties concerning the specific factors disclosed here and elsewhere in CannaRoyalty's periodic filings with Canadian securities regulators. When used in this news release, words such as "will, could, plan, estimate, expect, intend, may, potential, believe, should," and similar expressions, are forward- looking statements.

Forward-looking statements may include, without limitation, statements including the Company's expectations with respect to pursuing new opportunities, anticipated timing for release of the Company's financial results and filing of its final prospectus, and its future growth and other statements of fact.

Although CannaRoyalty has attempted to identify important factors that could cause actual results, performance or achievements to differ materially from those contained in the forward-looking statements,  there can be other factors that cause results, performance or achievements not to be as anticipated, estimated or intended, including, but not limited to: dependence on obtaining regulatory approvals; investing in target companies or projects which have limited or no operating history and are engaged in activities currently considered illegal under US Federal Laws; changes in laws; limited operating history; reliance on management; requirements for additional financing; competition; hindering market growth and state adoption due to inconsistent public opinion and perception of the medical-use and adult-use marijuana industry and; regulatory or political change.

There can be no assurance that such information will prove to be accurate or that management's expectations or estimates of future developments, circumstances or results will materialize. As a result of these risks and uncertainties, the results or events predicted in these forward-looking statements may differ materially from actual results or events.

Accordingly, readers should not place undue reliance on forward-looking statements. The forward-looking statements in this news release are made as of the date of this release. CannaRoyalty disclaims any intention or obligation to update or revise such information, except as required by applicable law, and CannaRoyalty does not assume any liability for disclosure relating to any other company mentioned herein.

Consolidated Statements of Loss and Comprehensive Loss
In Canadian dollars

			Three months ended March 31,
			2018		2017
Revenue			$	643,437	$	301,111
Cost of sales			(673,067)		(56,638)
Gross margin			(29,630)		244,473
Operating expenses
	Sales and marketing		478,516		236,860
	Research and development		75,965		476,241
	General and administrative		3,750,426		2,137,188
	Amortization of brands and technologies		175,107		202,472
		Loss from operations	(4,509,644)		(2,808,288)
Other income (expenses)
	Changes in fair value of investments		342,106		-
	Impairment of convertible notes receivable		(375,472)		-
	Profit from equity accounted investees, net of tax		453,804		942,397
	Foreign exchange loss		(76,030)		(125,652)
	Interest expense		(319,990)		(17,620)
	Adjustment from non-completion of share swap transaction		-		(183,475)
	Listing expense		-		(38,193)
	Gain on reclassification to assets held for sale		-		98,674
	Interest income		-		-
		Net loss before tax	(4,485,226)		(2,132,157)
	Current tax expense		(434)		-
	Deferred tax expense recovery		(168,813)		78,372
		Net loss for the period	$	(4,654,473)	$	(2,053,785)
Other comprehensive loss for the period
	Foreign currency translation differences		545,605		(87,180)
		Total comprehensive loss for the period	$	(4,108,868)	$	(2,140,965)
Net loss per common share - basic and diluted			$	(0.10)	$	(0.05)
Weighted average number of common shares outstanding - basic and diluted			45,075,695		38,865,970
Total net loss for the period attributable to:
	Owners of the company		$	(4,629,003)	$	(2,037,970)
	Attributable to non-controlling interest		(25,470)		(15,815)
			$	(4,654,473)	$	(2,053,785)
Total comprehensive loss for the period attributable to:
	Owners of the company		$	(4,083,398)	$	(2,125,150)
	Attributable to non-controlling interest		(25,470)		(15,815)
			$	(4,108,868)	$	(2,140,965)

Consolidated Statements of Financial Position
In Canadian dollars

			March 31, 2018		December 31, 2017
ASSETS
Current
	Cash		$	6,056,470	$	4,522,644
	Amounts receivable		1,099,646		1,429,123
	Inventory		3,015,273		270,169
	Prepaid and other assets		727,472		250,744
	Loans receivable - current		631,469		1,102,168
	Convertible notes - current		-		373,127
			11,530,330		7,947,975
Non-Current
	Loans receivable		-		66,421
	Interest in equity accounted investees		4,087,128		3,596,333
	Investments		17,665,449		17,243,342
	Royalty investments		7,311,573		5,834,613
	Property and equipment		1,329,338		1,084,098
	Intangible assets		12,528,608		5,607,598
	Goodwill		13,218,265		4,759,377
			56,140,361		38,191,782
		Total Assets	$	67,670,691	$	46,139,757
LIABILITIES
Current
	Amounts payable and accrued liabilities		$	6,898,672	$	1,606,689
	Loan payable		533,274		425,345
	Current tax liability		496,325		102,236
			7,928,271		2,134,270
Non-Current
	Convertible debt		1,461,614		1,431,950
	Line of credit		1,107,480		826,517
	Deferred tax liability		3,433,205		1,278,676
			6,002,299		3,537,143
		Total Liabilities	$	13,930,570	$	5,671,413
SHAREHOLDERS' EQUITY
	Share capital		$	61,233,717	$	50,007,891
	Share subscription and contingent shares		5,839,730		-
	Warrants reserve		2,575,947		4,149,703
	Contributed surplus		11,720,275		9,902,292
	Accumulated other comprehensive loss		(487,114)		(1,032,719)
	Accumulated deficit		(27,119,958)		(22,381,817)
	Non-controlling interest		(22,476)		(177,006)
		Shareholders' Equity	53,740,121		40,468,344
		Total Liabilities & Shareholders' Equity	$	67,670,691	$	46,139,757

Consolidated Statements of Cash Flows
In Canadian dollars

		Three months ended March 31
		2018		2017
CASH FLOWS FROM (USED IN) OPERATING ACTIVITIES
Net loss for the period		$	(4,654,473)	$	(2,053,785)
Items not affecting cash:
	Bad debts expense	(20,903)		(13,318)
	Non controlling interest	-		(15,815)
	Gain from equity accounted investees	(453,804)		(942,397)
	Amortization of property and equipment	45,268		41,742
	Amortization of intangibles	166,868		202,472
	Amortization of royalties	388,370		21,121
	Amortization of fees related to line of credit	197,630		-
	Share based compensation	1,940,043		1,158,396
	Deferred tax expense (recovery)	168,813		(78,372)
	Loss on impairment of convertible notes receivable	375,472		-
	Accretion of derivative assets and liabilities	14,664		-
	Gain on reclassification of assets held for sale	-		(98,674)
	Gain on investments	(342,106)		-
		(2,174,158)		(1,778,630)
Changes in non-cash items relating to operations:
	Decrease (increase) in amounts receivable	75,133		(249,641)
	Decrease in inventory	13,401		41,085
	Increase in prepaid and other assets	(288,276)		(58,918)
	(Increase) Decrease in accounts payable and accruals	440,819		(408,506)
	Increase in current tax liability	434		-
		(1,932,647)		(2,454,610)
CASH FLOWS FROM (USED IN) INVESTING ACTIVITIES
	Purchase of property and equipment	(20,530)		(70,304)
	Purchase of Kaya and Alta, net of cash received	733,321		-
	Purchase of interests in equity accounted investments	-		(1,601,218)
	Royalty financing arrangements	(1,290,000)		-
	Loans advanced to debtors, net of repayment	(916,360)		(664,535)
		(1,493,569)		(2,336,057)
CASH FLOWS FROM (USED IN) FINANCING ACTIVITIES
	Proceeds from shares in bought deal financing, net of issuance costs	-		10,963,049
	Proceeds from issuance of warrants, net of issuance costs	-		2,787,000
	Proceeds from exercise of warrants	4,738,146		29,250
	Proceeds from shares issued to minority holders of Trichome	180,000
	Proceeds from issuance of stock options	-		25,000
	Tax withholding paid on exercise of restricted share units	-		(13,110)
		4,918,146		13,791,189
Effect of movement of exchange rates on cash held		41,896		-
INCREASE (DECREASE) IN CASH		1,533,826		9,000,522
CASH, BEGINNING OF PERIOD		4,522,644		2,945,895
CASH, END OF PERIOD		$	6,056,470	$	11,946,417

SOURCE CannaRoyalty Corp.

Marc Lustig, CEO, [email protected], 1-844-556-5070, www.cannaroyalty.com; Jonathan Ross, LodeRock Advisors Inc., [email protected], 416-283-0178